Measurements of Bone Health after Thyroid-Stimulating Suppression Therapy in Postmenopausal Women with Differentiated Thyroid Carcinoma: Bone Mineral Density versus the Trabecular Bone Score
Background: Thyroid-stimulating hormone (TSH) suppression therapy is an important treatment modality for differentiated thyroid carcinoma (DTC), but it increases fracture risk. The aim of this study was to evaluate changes in bone mineral density (BMD) and trabecular bone score (TBS) in postmenopaus...
Main Authors: | Chae Won Chung, Hoon Sung Choi, Sung Hye Kong, Young Joo Park, Do Joon Park, Hwa Young Ahn, Sun Wook Cho |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/9/1964 |
Similar Items
-
Trabecular bone deterioration in differentiated thyroid cancer: Impact of long‐term TSH suppressive therapy
by: Federico Hawkins Carranza, et al.
Published: (2020-08-01) -
Application and prospect of trabecular bone score in differentiated thyroid cancer patients receiving thyrotropin suppression therapy
by: Bingyu Ran, et al.
Published: (2022-10-01) -
Association of Low Serum 25OHD Levels with Abnormal Bone Microarchitecture in Well-Differentiated Thyroid Cancer
by: Federico Hawkins Carranza, et al.
Published: (2020-12-01) -
Trabecular bone scores in young HIV-infected men: a matched case-control study
by: Youn Jeong Kim, et al.
Published: (2020-02-01) -
Trabecular bone score in obese patients with and without diabetes
by: Gordana Dzeletovic, et al.
Published: (2024-02-01)